vs

Side-by-side financial comparison of La Rosa Holdings Corp. (LRHC) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.

La Rosa Holdings Corp. is the larger business by last-quarter revenue ($20.2M vs $13.3M, roughly 1.5× OCULAR THERAPEUTIX, INC). La Rosa Holdings Corp. runs the higher net margin — -27.4% vs -488.0%, a 460.6% gap on every dollar of revenue. On growth, La Rosa Holdings Corp. posted the faster year-over-year revenue change (3.2% vs -22.4%). Over the past eight quarters, La Rosa Holdings Corp.'s revenue compounded faster (72.5% CAGR vs -5.3%).

V. La Rosa and Sons Macaroni Company was founded in 1914 by Vincenzo La Rosa, a Sicilian immigrant. The company eventually became one of the largest regional brands in the United States producing over 40 varieties of pasta.

Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.

LRHC vs OCUL — Head-to-Head

Bigger by revenue
LRHC
LRHC
1.5× larger
LRHC
$20.2M
$13.3M
OCUL
Growing faster (revenue YoY)
LRHC
LRHC
+25.6% gap
LRHC
3.2%
-22.4%
OCUL
Higher net margin
LRHC
LRHC
460.6% more per $
LRHC
-27.4%
-488.0%
OCUL
Faster 2-yr revenue CAGR
LRHC
LRHC
Annualised
LRHC
72.5%
-5.3%
OCUL

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
LRHC
LRHC
OCUL
OCUL
Revenue
$20.2M
$13.3M
Net Profit
$-5.5M
$-64.7M
Gross Margin
8.4%
88.0%
Operating Margin
-24.7%
-526.5%
Net Margin
-27.4%
-488.0%
Revenue YoY
3.2%
-22.4%
Net Profit YoY
-125.7%
-33.6%
EPS (diluted)
$-5.44
$-0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LRHC
LRHC
OCUL
OCUL
Q4 25
$13.3M
Q3 25
$20.2M
$14.5M
Q2 25
$23.2M
$13.5M
Q1 25
$17.5M
$10.7M
Q4 24
$17.7M
$17.1M
Q3 24
$19.6M
$15.4M
Q2 24
$19.1M
$16.4M
Q1 24
$13.1M
$14.8M
Net Profit
LRHC
LRHC
OCUL
OCUL
Q4 25
$-64.7M
Q3 25
$-5.5M
$-69.4M
Q2 25
$78.4M
$-67.8M
Q1 25
$-95.7M
$-64.1M
Q4 24
$-5.1M
$-48.4M
Q3 24
$-2.5M
$-36.5M
Q2 24
$-2.3M
$-43.8M
Q1 24
$-4.6M
$-64.8M
Gross Margin
LRHC
LRHC
OCUL
OCUL
Q4 25
88.0%
Q3 25
8.4%
87.8%
Q2 25
8.0%
85.6%
Q1 25
8.8%
88.2%
Q4 24
8.9%
92.8%
Q3 24
8.3%
89.9%
Q2 24
8.3%
90.8%
Q1 24
8.9%
91.0%
Operating Margin
LRHC
LRHC
OCUL
OCUL
Q4 25
-526.5%
Q3 25
-24.7%
-472.3%
Q2 25
-10.6%
-502.6%
Q1 25
-26.7%
-597.5%
Q4 24
-17.1%
-296.1%
Q3 24
-8.9%
-298.2%
Q2 24
-9.7%
-265.1%
Q1 24
-35.0%
-214.0%
Net Margin
LRHC
LRHC
OCUL
OCUL
Q4 25
-488.0%
Q3 25
-27.4%
-477.3%
Q2 25
337.8%
-503.9%
Q1 25
-546.5%
-598.7%
Q4 24
-28.7%
-283.3%
Q3 24
-12.5%
-236.6%
Q2 24
-12.2%
-266.3%
Q1 24
-35.1%
-438.9%
EPS (diluted)
LRHC
LRHC
OCUL
OCUL
Q4 25
$-0.27
Q3 25
$-5.44
$-0.38
Q2 25
$15.25
$-0.39
Q1 25
$-5.86
$-0.38
Q4 24
$28.54
$-0.25
Q3 24
$-16.49
$-0.22
Q2 24
$-12.49
$-0.26
Q1 24
$-0.35
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LRHC
LRHC
OCUL
OCUL
Cash + ST InvestmentsLiquidity on hand
$4.0M
$737.1M
Total DebtLower is stronger
$642.8K
Stockholders' EquityBook value
$1.6M
$654.3M
Total Assets
$21.7M
$808.1M
Debt / EquityLower = less leverage
0.41×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LRHC
LRHC
OCUL
OCUL
Q4 25
$737.1M
Q3 25
$4.0M
$344.8M
Q2 25
$5.1M
$391.1M
Q1 25
$2.9M
$349.7M
Q4 24
$1.4M
$392.1M
Q3 24
$1.8M
$427.2M
Q2 24
$1.6M
$459.7M
Q1 24
$1.1M
$482.9M
Total Debt
LRHC
LRHC
OCUL
OCUL
Q4 25
Q3 25
$642.8K
Q2 25
$644.3K
Q1 25
$645.9K
Q4 24
$647.6K
Q3 24
$649.2K
Q2 24
$650.8K
Q1 24
$652.4K
Stockholders' Equity
LRHC
LRHC
OCUL
OCUL
Q4 25
$654.3M
Q3 25
$1.6M
$258.2M
Q2 25
$3.4M
$305.9M
Q1 25
$-87.5M
$265.9M
Q4 24
$2.6M
$315.3M
Q3 24
$5.0M
$352.0M
Q2 24
$4.7M
$377.7M
Q1 24
$5.6M
$408.0M
Total Assets
LRHC
LRHC
OCUL
OCUL
Q4 25
$808.1M
Q3 25
$21.7M
$410.9M
Q2 25
$22.9M
$451.3M
Q1 25
$21.0M
$405.9M
Q4 24
$19.4M
$457.9M
Q3 24
$19.7M
$490.4M
Q2 24
$18.7M
$517.1M
Q1 24
$16.3M
$538.9M
Debt / Equity
LRHC
LRHC
OCUL
OCUL
Q4 25
Q3 25
0.41×
Q2 25
0.19×
Q1 25
Q4 24
0.25×
Q3 24
0.13×
Q2 24
0.14×
Q1 24
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LRHC
LRHC
OCUL
OCUL
Operating Cash FlowLast quarter
$-1.3M
$-54.2M
Free Cash FlowOCF − Capex
$-57.1M
FCF MarginFCF / Revenue
-430.9%
Capex IntensityCapex / Revenue
21.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-216.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LRHC
LRHC
OCUL
OCUL
Q4 25
$-54.2M
Q3 25
$-1.3M
$-50.7M
Q2 25
$-1.4M
$-55.2M
Q1 25
$-3.5M
$-44.7M
Q4 24
$-1.1M
$-39.4M
Q3 24
$-591.6K
$-36.6M
Q2 24
$-803.1K
$-24.8M
Q1 24
$-538.3K
$-33.9M
Free Cash Flow
LRHC
LRHC
OCUL
OCUL
Q4 25
$-57.1M
Q3 25
$-56.7M
Q2 25
$-56.5M
Q1 25
$-46.6M
Q4 24
$-39.6M
Q3 24
$-36.6M
Q2 24
$-25.5M
Q1 24
$-34.1M
FCF Margin
LRHC
LRHC
OCUL
OCUL
Q4 25
-430.9%
Q3 25
-390.0%
Q2 25
-419.7%
Q1 25
-435.6%
Q4 24
-232.0%
Q3 24
-237.6%
Q2 24
-155.4%
Q1 24
-231.1%
Capex Intensity
LRHC
LRHC
OCUL
OCUL
Q4 25
21.4%
Q3 25
41.2%
Q2 25
9.3%
Q1 25
18.1%
Q4 24
1.2%
Q3 24
0.6%
Q2 24
4.5%
Q1 24
1.7%
Cash Conversion
LRHC
LRHC
OCUL
OCUL
Q4 25
Q3 25
Q2 25
-0.02×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LRHC
LRHC

Real Estate Residential Brokerage Services$16.8M83%
Transferred Over Time$3.5M17%

OCUL
OCUL

Segment breakdown not available.

Related Comparisons